Cure Brain Cancer Foundation is thrilled to announce the world’s largest, brain cancer-dedicated, Clinical Accelerator program,...
Cure Brain Cancer Foundation is thrilled to announce the world’s largest, brain cancer-dedicated, Clinical Accelerator program,...
Cure Brain Cancer Foundation invests in GBM AGILE, connecting Australians to an innovative clinical trial program...
Cure Brain Cancer Foundation is excited to announce one of the biggest developments ever, in DIPG...
GBM AGILE, the groundbreaking clinical trial, is now open for enrollment in Australia. Patients at Royal...
Cure Brain Cancer Foundation (CBCF) is pleased to share a final report from the team at...
A funded Glioblastoma (GBM) clinical trial has shown positive safety and bioimaging results, which took place...
Originally opened in 2021, PNOC019, a phase 1 clinical trial, was designed to evaluate the immunotherapy...
Cure Brain Cancer Foundation is excited to share a progress update from Professor David Ziegler of...
The Foundation is excited to share that the DIPG Collaborative have awarded another grant, worth up...